From Spectra to Structure: An Interview with Novogaia’s Tess Bevers
By Henry Thomas
April 15, 2026
Novogaia’s transformer-based model converts untargeted mass spectra into structural predictions for early-stage drug discovery
7 min read
False
By Henry Thomas
April 15, 2026
Novogaia’s transformer-based model converts untargeted mass spectra into structural predictions for early-stage drug discovery
7 min read
By James Strachan
April 8, 2026
Microdroplets formed during electrospray ionization may trigger chemical reactions that help explain a substantial portion of the “dark metabolome” – though some researchers question their relevance under typical metabolomics conditions
7 min read
By Henry Thomas
April 7, 2026
A multimodal MSI approach reveals how plaque-associated lipid signatures differ across brain regions in Alzheimer’s disease
6 min read
April 1, 2026
Proteomics and metabolic assays show how spermidine-linked signaling diverges in healthy and malignant cells
2 min read
March 31, 2026
Fiber-based imaging platform reveals nanoscale heterogeneity and drug-specific metabolic fingerprints in cancer cells
1 min read
March 24, 2026
Cell culture model reveals lipid remodeling and oxidative stress following prolonged PFAS exposure
2 min read
March 23, 2026
Thomas Letzel reflects on the evolution of non-target screening and why interdisciplinary insights are key to its future
6 min read
March 17, 2026
Serum lipid profiling reveals PFAS-linked shifts in triglyceride and membrane lipid species
2 min read
March 17, 2026
Chemometric analysis identifies lipid markers linked to thermal deterioration of frying oils
2 min read
By James Strachan
February 12, 2026
One of the most abundant metabolites in human urine has been misidentified in nearly half of published reports, study finds
5 min read
False
False
False